Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Ischaemic-Reperfused Hearts in Adult Rats with Established Chronic Kidney Disease
- Author:
Gehane M HAMED
1
;
Wessam E MORSY
;
Manal S ABD-EL HAMID
;
Arwa Abd el moniem HASSAN
;
Fatma A ABU ZAHRA
Author Information
- Publication Type:Original Article
- Keywords: Chronic kidney disease; Nephrectomy; Bone marrow-derived stem cells; Isolated perfused heart study
- MeSH: Adult; Animals; Arterial Pressure; Body Weight; Creatinine; Electrocardiography; Heart Rate; Heart Ventricles; Heart; Humans; Hypertrophy; In Vitro Techniques; Kidney; Mesenchymal Stromal Cells; Myocytes, Cardiac; Nephrectomy; Plasma; Rats; Regeneration; Relaxation; Renal Insufficiency, Chronic; Reperfusion; Stem Cells; Urea; Weights and Measures
- From:International Journal of Stem Cells 2019;12(2):304-314
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND OBJECTIVES: Bone marrow-derived mesenchymal stem cells (BM-MSCs) are adult multipotent non-haematopoietic stem cells that have regeneration potential. The current study aimed to detect the ability of BM-MSCs to improve kidney and cardiac functions in adult rats with established chronic kidney disease. METHODS: Rats were divided into sham-operated control, untreated sub totally nephrectomised and treated sub totally nephrectomised groups. Body weight, kidney and cardiac tissue weights, plasma creatinine and urea levels and arterial blood pressure were measured. ECG was recorded, and an in vitro isolated heart study was performed. Results: Stem cell treatment decreased the elevated plasma creatinine and urea levels and decreased systolic, diastolic and mean arterial blood pressure values. These changes were accompanied by a decrease in glomerular hypertrophy with apparent normal renal parenchyma. Additionally, BM-MSCs shortened Q-To and Q-Tc intervals, all time to peak tension values, the half relaxation value at 30 min of reperfusion and the contraction time at 15 and 30 min of reperfusion. Moreover, stem cell treatment significantly increased the heart rate, QRS voltage, the peak tension at the 15- and 30-min reperfusion time points and the peak tension per left ventricle at the 30-min reperfusion time point compared to the pre-ischaemia baseline. BM-MSCs resolve inter muscular oedema and lead to the re-appearance of normal cardiomyocytes. This improvement occurs with the observations of BM-MSCs in renal and heart tissues. CONCLUSIONS: BM-MSCs can attenuate chronic kidney disease progression and the associated cardiac electrophysiological and inotropic dysfunction.
